L. Laterveer

1.6k total citations
19 papers, 1.3k citations indexed

About

L. Laterveer is a scholar working on Hematology, Oncology and Genetics. According to data from OpenAlex, L. Laterveer has authored 19 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Hematology, 8 papers in Oncology and 6 papers in Genetics. Recurrent topics in L. Laterveer's work include Hematopoietic Stem Cell Transplantation (7 papers), Mesenchymal stem cell research (3 papers) and Platelet Disorders and Treatments (3 papers). L. Laterveer is often cited by papers focused on Hematopoietic Stem Cell Transplantation (7 papers), Mesenchymal stem cell research (3 papers) and Platelet Disorders and Treatments (3 papers). L. Laterveer collaborates with scholars based in Netherlands, Belgium and Austria. L. Laterveer's co-authors include Roel Willemze, Willem E. Fibbe, WE Fibbe, I. J. D. Lindley, R. Willemze, Ghislain Opdenakker, Stefan Masure, Liesbet Paemen, Hans Pruijt and Jan Visser and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Blood and The Journal of Immunology.

In The Last Decade

L. Laterveer

19 papers receiving 1.3k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
L. Laterveer Netherlands 15 648 437 316 244 144 19 1.3k
Claudia C. Folman Netherlands 18 725 1.1× 129 0.3× 174 0.6× 243 1.0× 169 1.2× 39 1.2k
Bernard R. Greenberg United States 19 406 0.6× 203 0.5× 554 1.8× 206 0.8× 303 2.1× 64 1.5k
Inmaculada Heras Spain 17 494 0.8× 163 0.4× 281 0.9× 163 0.7× 112 0.8× 44 962
Luca Laurenti Italy 14 274 0.4× 351 0.8× 277 0.9× 319 1.3× 389 2.7× 41 1.1k
D. Kyriakou Greece 21 368 0.6× 166 0.4× 234 0.7× 190 0.8× 133 0.9× 44 872
Esteban Abella United States 17 551 0.9× 233 0.5× 512 1.6× 178 0.7× 155 1.1× 56 1.3k
P. Meusers Germany 18 519 0.8× 192 0.4× 689 2.2× 201 0.8× 386 2.7× 43 1.5k
Nicola Fracchiolla Italy 21 511 0.8× 376 0.9× 599 1.9× 566 2.3× 359 2.5× 61 1.9k
Lilian Reich United States 25 1.3k 2.0× 553 1.3× 585 1.9× 387 1.6× 307 2.1× 50 2.2k
John L. Reagan United States 20 282 0.4× 453 1.0× 580 1.8× 403 1.7× 172 1.2× 107 1.5k

Countries citing papers authored by L. Laterveer

Since Specialization
Citations

This map shows the geographic impact of L. Laterveer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by L. Laterveer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites L. Laterveer more than expected).

Fields of papers citing papers by L. Laterveer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by L. Laterveer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by L. Laterveer. The network helps show where L. Laterveer may publish in the future.

Co-authorship network of co-authors of L. Laterveer

This figure shows the co-authorship network connecting the top 25 collaborators of L. Laterveer. A scholar is included among the top collaborators of L. Laterveer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with L. Laterveer. L. Laterveer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Visser, Otto, et al.. (2020). Bilateral breast implant associated chronic lymphocytic leukemia/small lymphocytic lymphoma (CLL/SLL): A case report. International Journal of Surgery Case Reports. 71. 341–345. 5 indexed citations
2.
Timmer-Bonte, Johanna N.H., et al.. (2020). Lipegfilgrastim for prophylaxis of chemotherapy-induced neutropenia in Dutch patients.. PubMed. 78(5). 270–276. 2 indexed citations
3.
Veeger, Nic J.G.M., Marinus van Marwijk Kooy, Aart Beeker, et al.. (2013). Azacitidine results in comparable outcome in newly diagnosed AML patients with more or less than 30% bone marrow blasts. Leukemia Research. 37(8). 877–882. 24 indexed citations
4.
Nijkeuter, Mathilde, Maaike Söhne, Lidwine W. Tick, et al.. (2007). The Natural Course of Hemodynamically Stable Pulmonary Embolism. CHEST Journal. 131(2). 517–523. 103 indexed citations
5.
Kraaij, Marian G.J. van, Leontine J. R. van Elden, Anton M. van Loon, et al.. (2005). Frequent Detection of Respiratory Viruses in Adult Recipients of Stem Cell Transplants with the Use of Real-Time Polymerase Chain Reaction, Compared with Viral Culture. Clinical Infectious Diseases. 40(5). 662–669. 70 indexed citations
6.
Lokhorst, Henk M., Leo F. Verdonck, L. Laterveer, et al.. (2004). The occurrence of graft-versus-host disease is the major predictive factor for response to donor lymphocyte infusions in multiple myeloma. Blood. 103(11). 4362–4364. 130 indexed citations
7.
Laterveer, L.. (2003). Pro-poor health policies in poverty reduction strategies. Health Policy and Planning. 18(2). 138–145. 27 indexed citations
8.
Pruijt, Hans, Willem E. Fibbe, L. Laterveer, et al.. (1999). Prevention of interleukin-8-induced mobilization of hematopoietic progenitor cells in rhesus monkeys by inhibitory antibodies against the Metalloproteinase gelatinase B (MMP-9). Proceedings of the National Academy of Sciences. 96(19). 10863–10868. 196 indexed citations
9.
Zijlmans, J. M. J. M., Jan Visser, L. Laterveer, et al.. (1998). The early phase of engraftment after murine blood cell transplantation is mediated by hematopoietic stem cells. Proceedings of the National Academy of Sciences. 95(2). 725–729. 95 indexed citations
10.
Fibbe, W.E., Hans Pruijt, L. Laterveer, et al.. (1997). Mechanisms of stem cell mobilization in mice. Experimental Hematology. 25. 6–6. 1 indexed citations
11.
Laterveer, L., J. M. J. M. Zijlmans, E. Liehl, Roel Willemze, & Willem E. Fibbe. (1996). Accelerated platelet reconstitution following transplantation of bone marrow cells derived from IL-6-treated donor mice. Annals of Hematology. 73(5). 239–245. 9 indexed citations
12.
Laterveer, L., et al.. (1996). Improved survival of lethally irradiated recipient mice transplanted with circulating progenitor cells mobilized by IL-8 after pretreatment with stem cell factor.. PubMed. 24(12). 1387–93. 31 indexed citations
13.
16.
Laterveer, L., et al.. (1993). Continuous infusion of interleukin-6 in sublethally irradiated mice accelerates platelet reconstitution and the recovery of myeloid but not of megakaryocytic progenitor cells in bone marrow.. PubMed. 21(13). 1621–7. 19 indexed citations
17.
Fibbe, Willem E., Malcolm Hamilton, L. Laterveer, et al.. (1992). Sustained engraftment of mice transplanted with IL-1-primed blood-derived stem cells. The Journal of Immunology. 148(2). 417–421. 61 indexed citations
18.
Laterveer, L., et al.. (1987). A Simple Method for Determination of Corneal Epithelial Permeability in Humans. Current Eye Research. 6(11). 1327–1334. 48 indexed citations
19.
Best, J A van, J. P. Kappelhof, L. Laterveer, & J.A. Oosterhuis. (1987). Blood aqueous barrier permeability versus age by fluorophotometry. Current Eye Research. 6(7). 855–863. 35 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026